|
|
|
|
- 130+ participants
- In excess of 75 individual organisations represented
- 33 hours of presentations
- Over 10 hours of networking
- 91% of our attendees ranked the congress as good or excellent
- 30 different countries
› Benefits of sponsoring
|
Conference:
Pre-conference workshop
23 Feb 9am - 5pm
Day 1
24 Feb 8.30am - 6:00pm
Day 2
25 Feb 8.30am - 5:30pm
Post-conference workshop
26 Feb 9am - 5pm
Venue:
The Royal Horseguards Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
|
 Tony Foreman,
Commercial Director and Chief Executive Officer Almus Pharmaceuticals Tony Foreman is the Commercial Director of Alliance Healthcare, part of the international pharmacy-led Health and Beauty group, Alliance Boots. With more than 20 years experience in the pharmaceutical industry, Tony has been the driving force behind some of the most exciting recent innovations in European pharmaceutical wholesaling, not least Almus Pharmaceuticals, of which he is also CEO. Launched just 5 years ago in the UK, the Almus range of generic medicines has won numerous awards, and has been described as the gold standard in patient-safe packaging. It is now present in 4 European markets and enjoys a 20 per cent market share by volume in the UK.
Tony is currently working on expanding the reach of Almus, and of Alliance Boots patient care range Alvita. In addition, he oversees global sourcing of generics, surgicals and diagnostic products.
Most recently, Tony has established Almus Pharmaceuticals USA, a joint venture company set up in 2007 with Cardinal Health. Serving as a Director on the Board of Almus Pharmaceuticals USA, Tonys role along with the other board directors is to launch a range of Almus medicines in the US market.Appearing: Day two - Thurs 25 Feb 2010 3.30pm Wholesale and purchasing environment for generic medicines in Western Europe• What decisions big wholesalers make when selecting a generics label in their market
• How much do patients care about the brand?
• How do they see the generics medicines market evolving?
Tony Foreman, Commercial Director and Chief Executive Officer,
Almus Pharmaceuticals |
|
|
|
|
Robert Wessman
Executive Chairman
Alvogen
Petra Danielsohn-Weil
European President, Established Brands
Pfizer
Satish Reddy
Chief Operating Officer & Managing Director
Dr Reddy's Laboratories
Gerard van Odijk
President & Chief Executive Officer
Teva Pharmaceuticals Europe
Honorable Henry A Waxman
Member of Congress
United States of Americas
|
|
|
|
|
|
|
|
|
|
